Strategies to promote HDL-C: an emerging therapeutic target
Open Access
- 11 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (9) , 853-855
- https://doi.org/10.1093/eurheartj/ehi218
Abstract
This editorial refers to ‘High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial’† by A.G. Olsson et al., on page 890Keywords
This publication has 10 references indexed in Scilit:
- High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trialEuropean Heart Journal, 2005
- Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2Circulation, 2004
- Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular diseaseJournal of Clinical Investigation, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL CholesterolNew England Journal of Medicine, 2004
- Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary SyndromesJAMA, 2003
- High density lipoproteins (HDLs) and atherosclerosis; the unanswered questionsAtherosclerosis, 2003
- Cholesteryl Ester Transfer ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001